571
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT)

& ORCID Icon
Pages 140-145 | Received 26 May 2020, Accepted 22 Jul 2020, Published online: 26 Nov 2020

References

  • Anderson, T., R. Petranker, A. Christopher, D. Rosenbaum, C. Weissman, L. A. Dinh-Williams, K. Hui, and E. Hapke. 2019. Psychedelic microdosing benefits and challenges: An empirical codebook. Harm Reduction Journal 16 (1):43. doi:10.1186/s12954-019-0308-4.
  • Baguley, D., D. McFerran, and D. Hall. 2013. Tinnitus. The Lancet 382 (9904):1600–07. doi:10.1016/S0140-6736(13)60142-7.
  • Baldo, P., C. Doree, P. Molin, D. McFerran, and S. Cecco. 2012. Antidepressants for patients with tinnitus. Cochrane Database System Review (9):Cd003853.
  • Cameron, L. P., A. Nazarian, and D. E. Olson. 2020. Psychedelic microdosing: Prevalence and subjective effects. Journal of Psychoactive Drugs 52(2):113-122..
  • Caperton, K. K., and A. M. Thompson. 2011. Activation of serotonergic neurons during salicylate-induced tinnitus. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology 32 (2):301–07. doi:10.1097/MAO.0b013e3182009d46.
  • Carbonaro, T. M., and M. B. Gatch. 2016. Neuropharmacology of N,N-dimethyltryptamine. Brain Research Bulletin 126 (Pt 1):74–88. doi:10.1016/j.brainresbull.2016.04.016.
  • Carhart-Harris, R. L., and G. M. Goodwin. 2017. The therapeutic potential of psychedelic drugs: Past, present, and future. Neuropsychopharmacology 42 (11):2105–13.
  • Clewes, J. 2012. A case report of onset of tinnitus following discontinuation of antidepressant and a review of the literature. The Primary Care Companion for CNS Disorders 14 (1):PCC.11br01218.
  • Doherty, M. J. 2009. Algorithms for assessing the probability of an adverse drug reaction. Respiratory Medicine CME 2 (2):63–67. doi:10.1016/j.rmedc.2009.01.004.
  • Dos Santos, R. G., J. C. Bouso, and J. E. C. Hallak. 2017. Ayahuasca, dimethyltryptamine, and psychosis: A systematic review of human studies. Therapeutic Advances in Psychopharmacology 7 (4):141–57. doi:10.1177/2045125316689030.
  • Eggermont, J. J. 2008. Role of auditory cortex in noise- and drug-induced tinnitus. American Journal of Audiology 17 (2):S162–169. doi:10.1044/1059-0889(2008/07-0025).
  • Entranced. (2017). “DMT is giving me tinnitus.” DMT Nexus.
  • Fadiman, J., and S. Korb. 2019. Might microdosing psychedelics be safe and beneficial? An initial exploration. Journal of Psychoactive Drugs 51 (2):118–22. doi:10.1080/02791072.2019.1593561.
  • Felix, R. A., 2nd, B. Gourevitch, and C. V. Portfors. 2018. Subcortical pathways: Towards a better understanding of auditory disorders. Hearing Research 362:48–60. doi:10.1016/j.heares.2018.01.008.
  • Figueiredo, R. R., A. A. Azevedo, and N. D. O. Penido. 2016. Positive association between Tinnitus and arterial hypertension. Frontiers in Neurology 7:171–171. doi:10.3389/fneur.2016.00171.
  • Food and Drug Administration (FDA). (2020). FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market.
  • Fuentes, J. J., F. Fonseca, M. Elices, M. Farré, and M. Torrens. 2020. Therapeutic use of LSD in psychiatry: A systematic review of randomized-controlled clinical trials 10(943).
  • Haider, H. F., T. Bojić, S. F. Ribeiro, J. Paço, D. A. Hall, and A. J. Szczepek. 2018. Pathophysiology of subjective Tinnitus: Triggers and maintenance 12(866).
  • Halpern, J. H., A. G. Lerner, and T. Passie. 2018. A review of hallucinogen persisting perception disorder (HPPD) and an exploratory study of subjects claiming symptoms of HPPD. Current Topics in Behavioral Neurosciences 36:333–60.
  • Hutcheson, J. D., V. Setola, B. L. Roth, and W. D. Merryman. 2011. Serotonin receptors and heart valve disease–it was meant 2B. Pharmacology & Therapeutics 132 (2):146–57. doi:10.1016/j.pharmthera.2011.03.008.
  • Hutten, N., N. L. Mason, P. C. Dolder, and K. P. C. Kuypers. 2019. Motives and side-effects of microdosing with psychedelics among users. The International Journal Of Neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 22 (7):426–34. doi:10.1093/ijnp/pyz029.
  • Joedirt. (2011). “Tinnitus/Ear Ringing.” DMT Nexus.
  • Krebs, T. S., and P.-Ø. Johansen. 2013a. Over 30 million psychedelic users in the United States”. F1000Researchart 2:98–98.doi: 10.12688/f1000research.2-98.v1
  • Krebs, T. S., P. O. Johansen, and L. Lu. 2013b. Psychedelics and mental health: A population study. PLoS One 8 (8):e63972. doi:10.1371/journal.pone.0063972
  • Kuypers, K. P., L. Ng, D. Erritzoe, G. M. Knudsen, C. D. Nichols, D. E. Nichols, L. Pani, A. Soula, and D. Nutt. 2019. Microdosing psychedelics: More questions than answers? An overview and suggestions for future research. Journal of Psychopharmacology 33 (9):1039-1057. (Oxford, England) 269881119857204.
  • Liechti, M. E. 2017. Modern Clinical Research on LSD. Neuropsychopharmacology 42 (11):2114–27. doi:10.1038/npp.2017.86.
  • Luo, B., L. Hu, C. Liu, Y. Guo, and H. Wang. 2016. Activation of 5-HT2A/C receptor reduces glycine receptor-mediated currents in cultured auditory cortical neurons. Amino Acids 48 (2):349–56. doi:10.1007/s00726-015-2086-y.
  • Malcolm, B. J., and K. C. Lee. 2017. Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness? Mental Health Clinician 7 (1):39–45. doi:10.9740/mhc.2017.01.039.
  • Meikle, M. B., J. A. Henry, S. E. Griest, B. J. Stewart, H. B. Abrams, R. McArdle, P. J. Myers, C. W. Newman, S. Sandridge, D. C. Turk, et al. 2012. The tinnitus functional index: Development of a new clinical measure for chronic, intrusive tinnitus. Ear and Hearing 33 (2):153–76.
  • Mithoefer, M. C., A. A. Feduccia, L. Jerome, A. Mithoefer, M. Wagner, Z. Walsh, S. Hamilton, B. Yazar-Klosinski, A. Emerson, and R. Doblin. 2019. MDMA-assisted psychotherapy for treatment of PTSD: Study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology 236:2735–45. doi:10.1007/s00213-019-05249-5.
  • Nichols, D. E. 2016. Psychedelics. Pharmacological Reviews 68 (2):264–355.
  • Parrott, A. C. 2012. MDMA and 5-HT neurotoxicity: The empirical evidence for its adverse effects in humans - no need for translation. British Journal of Pharmacology discussion 1521-1512. 166 (5):1518–20. doi:10.1111/j.1476-5381.2012.01941.x.
  • Polito, V., R. J. Stevenson, and D. Arnone. 2019. A systematic study of microdosing psychedelics. PLoS One 14 (2):e0211023. doi:10.1371/journal.pone.0211023.
  • Reddit. (2017). “DMT does actually gives you permanent Tinnitus (ear ringing)?” Accessed July 15th, 2020. https://www.reddit.com/r/DMT/comments/5zjlgp/dmt_does_actually_gives_you_permanent_tinnitus/.
  • Reddit. (2019). “Deaf friend with Tinnitus will be trying DMT next month. His Tinnitus gets worse during LSD and shroom trips and he can feel sound at the base of his skull. Has anyone found Tinnitus to be unbearable on DMT?” Accessed https://www.reddit.com/search/?q=dmt%20and%20tinnitus
  • Salling, M. C., and N. L. Harrison. 2014. Strychnine-sensitive glycine receptors on pyramidal neurons in layers II/III of the mouse prefrontal cortex are tonically activated. Journal of Neurophysiology 112 (5):1169–78. doi:10.1152/jn.00714.2013.
  • Seligmann, H., L. Podoshin, J. Ben-David, M. Fradis, and M. Goldsher. 1996. Drug-induced tinnitus and other hearing disorders. Drug Safety : An International Journal of Medical Toxicology and Drug Experience 14 (3):198–212. doi:10.2165/00002018-199614030-00006.
  • Sessa, B. 2015. Turn on and tune in to evidence-based psychedelic research. Lancet Psychiatry 2 (1):10–12. doi:10.1016/S2215-0366(14)00120-5.
  • Shargorodsky, J., G. C. Curhan, and W. R. Farwell. 2010. Prevalence and characteristics of Tinnitus among US Adults. The American Journal of Medicine 123 (8):711–18. doi:10.1016/j.amjmed.2010.02.015.
  • Strassman, R. J., C. R. Qualls, E. H. Uhlenhuth, and R. Kellner. 1994. Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Archives of General Psychiatry 51 (2):98–108.
  • Tang, Z. Q., and L. O. Trussell. 2015. Serotonergic regulation of excitability of principal cells of the dorsal cochlear nucleus. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 35 (11):4540–51. doi:10.1523/JNEUROSCI.4825-14.2015.
  • Thomas, K., B. Malcolm, and D. Lastra. 2017. Psilocybin-assisted therapy: A review of a novel treatment for psychiatric disorders. Journal of Psychoactive Drugs 49 (5):1–10.
  • Winne, J., B. C. Boerner, T. Malfatti, E. Brisa, J. Doerl, I. Nogueira, K. E. Leao, and R. N. Leao. 2020. Anxiety-like behavior induced by salicylate depends on age and can be prevented by a single dose of 5-MeO-DMT. Experimental Neurology 326:113175. doi:10.1016/j.expneurol.2020.113175.
  • Zhao, Y., Q. Song, X. Li, and C. Li. 2016. Neural hyperactivity of the central auditory system in response to peripheral damage. Neural Plasticity 2016:2162105. doi:10.1155/2016/2162105.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.